Summaries by Inventor Mullen, Mary

Functional Biomarkers of Platinum Chemotherapy and PARP Inhibitor Response
Lomonosova, Elena ; Mullen, Mary ; Verma, Priyanka ; Zhao, Peinan
T-020659

— T-020659 — Functional Biomarkers of Platinum Chemotherapy and PARP Inhibitor Response Technology Description Most patients diagnosed with high-grade serous ovarian cancer (HGSOC) undergo first-line platinum therapy and PARP inhibitor maintenance therapy. However, the degree to which HGSOC p…